Story
Healthcare Sector Offers Durable Growth Amid AI Focus, JPMorgan Says

Summary
JPMorgan analysts highlight the healthcare sector as an overlooked opportunity, citing its deep underperformance, attractive valuations, and durable growth prospects in a market heavily concentrated on AI.
JPMorgan has reiterated a favorable view on the S&P 500's healthcare sector, arguing that its risk/reward profile is attractive after one of its most significant periods of underperformance in decades. Analysts at the firm believe the sector has been increasingly overlooked as investor capital remains narrowly focused on artificial intelligence.
A Contrarian Opportunity
In a note published Tuesday, JPMorgan strategist Dubravko Lakos-Bujas said healthcare "offers a rare combination of durable growth, Technology-like profitability, attractive valuation and diversification benefits." The firm noted this is particularly relevant at a time when many investment portfolios are heavily concentrated in the AI theme.
This intense focus on AI and related technologies over the past three years has left one of the market's largest and most historically stable growth sectors behind, according to the bank's analysis.
A History of Underperformance
JPMorgan detailed the extent of the sector's recent weakness, which has created what it sees as a compelling entry point for investors. Key points from their analysis include:
Ad- The U.S. healthcare sector has lagged the broader S&P 500 every year since the launch of ChatGPT in 2022.
- It has experienced five separate drawdowns exceeding 10% during one of the market's strongest recent rallies.
- As a result, the sector's weight in the S&P 500 index has fallen from a peak of nearly 16% to approximately 9%, dropping it from the second-largest to the fifth-largest sector.
Weak sentiment has been driven by concerns over drug pricing reform, reimbursement pressures, and broader policy uncertainty. JPMorgan also noted that healthcare has become a popular "funding short" for investors to finance long positions in crowded AI trades, contributing to a major reset in investor positioning.
An Approaching Inflection Point
Looking ahead, the firm believes the sector is nearing a turning point. "With valuations still favorable (26%ile vs. market) and earnings growth poised to accelerate materially in 2027, we believe the sector is approaching a more durable inflection point,” Lakos-Bujas stated.
JPMorgan suggested that a potential gridlock outcome in upcoming elections could alleviate policy concerns. Furthermore, the analysts see a low bar for the sector to deliver upside surprises from productivity gains derived from its own adoption of AI technologies.
Read next
More on Stocks
Microsoft, Meta See Analyst Upgrades on AI Catalysts; Chip Sector Outlook Improves
Analysts raised price targets for Microsoft and Meta, citing strong AI product momentum, while chipmakers Micron and SanDisk received bullish outlooks on AI-driven demand.

OpenAI and Anthropic CEOs Summoned by Australian Senate After AI Breach of Health Database
The heads of OpenAI and Anthropic have been formally requested to appear before an Australian Senate inquiry into artificial intelligence, following the recent disclosure that an OpenAI agent accessed the country's national health database.

Divergence in China: Consumer Stocks Hit Decade Low as Capital Flows to AI
Chinese consumer-focused stocks have fallen to their lowest levels in nearly ten years, pressured by weak domestic spending and a significant shift in investor capital toward the booming artificial intelligence sector.

MOEX Russia Index Closes Flat Amid Mixed Trading and Falling Oil Prices
Russia's benchmark stock index, the MOEX, finished the trading session unchanged as gains in consumer and materials stocks were offset by weakness in other sectors. The flat close came despite a drop in global oil prices and a strengthening of the Russian ruble.